Abstract:Background: Kidney renal clear cell carcinoma (KIRC) is an immunogenic tumor, and immune infiltrates are relevant to patients' therapeutic response and prognosis. NDUFS1 , the core subunit of mitochondrial complex I, has been reported to be associated with KIRC patients' prognosis. However, the upstream regulator for NDUFS1 and their correlations with immune infiltration remain unclear. Methods: The expression of NDUFS genes in KIRC and their influences on patients' survival were investigated by UALCAN, ENCORI, Oncomine, TIMER as well as Kaplan-Meier Plotter. miRNAs regulating NDUFS1 were predicted and analyzed by TargetScan and ENCORI. The correlations between NDUFS1 expression and immune cell infiltration or gene marker sets of immune infiltrates were analyzed via TIMER. The overall survival in high/low NDUFS1 or hsa-miR-320b expressed KIRC patients with or without immune infiltrates were analyzed via Kaplan-Meier Plotter. The combined NDUFS1 expression and/or CD4 + T cell infiltration on KIRC patients' overall survival were validated by multiplexed immunofluorescence (mIF) staining in tissue microarray (TMA). Furthermore, the influences of NDUFS1 expression on the chemotaxis of CD4 + T cells to KIRC cells were performed by transwell migration assays. Results: We found that the low expression of NDUFS1 mRNA and protein in KIRC was correlated with unfavorable patients' survival and poor infiltration of CD4 + T cells. In patients with decreased CD4 + T cell infiltration whose pathological grade less than III, TMA mIF staining showed that low expression of NDUFS1 had significantly poor OS than that with high expression of NDUFS1 did. Furthermore, hsa-miR-320b, a possible negative regulator of NDUFS1 , was highly expressed in KIRC. And, low NDUFS1 or high hsa-miR-320b consistently correlated to unfavorable outcomes in KIRC patients with decreased CD4 + T cell infiltration. In vitro , NDUFS1 overexpression significantly increased the chemotaxis of CD4 + T cell to KIRC cells. Conclusion: Together, NDUFS1 , upregulated by decreased hsa-miR-320b expression in KIRC patients, might act as a biomarker for CD4 + T cell infiltration. And, the combination of NDUFS1 with CD4 + T cell infiltration predicts favorable prognosis in KIRC.

A Novel Function of NUCB2 in Promoting the Development and Invasion of Renal Cell Carcinoma

Nucleobindin 2 (Nucb2) In Renal Cell Carcinoma: A Novel Factor Associated With Tumor Development

High NUCB2 Expression Level Represents an Independent Negative Prognostic Factor in Chinese Cohorts of Non-Metastatic Clear Cell Renal Cell Carcinoma Patients

High NUCB2 Expression Level is Associated with Metastasis and May Promote Tumor Progression in Colorectal Cancer

High Expression of NUCB2 Promotes Papillary Thyroid Cancer Cells Proliferation and Invasion

NUCB2 promotes hepatocellular carcinoma cell growth and metastasis by activating the E2F4/PTGR1 axis

High expression of nucleobindin 2 mRNA: an independent prognostic factor for overall survival of patients with prostate cancer

Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer

NUCB2 Inhibition Antagonizes Osteosarcoma Progression and Promotes Anti-Tumor Immunity through Inactivating NUCKS1/CXCL8 Axis

High expression of KPNA2 defines poor prognosis in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy

Knockdown of the Nucleosome Binding Protein 1 Inhibits the Growth and Invasion of Clear Cell Renal Cell Carcinoma Cells in Vitro and in Vivo

Cannabinoid Receptor 2 As a Novel Target for Promotion of Renal Cell Carcinoma Prognosis and Progression

UBN2 Promotes Tumor Progression Via the Ras/MAPK Pathway and Predicts Poor Prognosis in Colorectal Cancer

NR1B2 Suppress Kidney Renal Clear Cell Carcinoma (KIRC) Progression by Regulation of LATS 1/2-YAP Signaling.

Low Neighbor of Brca1 Gene Expression Predicts Poor Clinical Outcome and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.

NUCB2: Roles in Physiology and Pathology

Decreased Expression of Long Non-Coding RNA NBAT-1 is Associated with Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma.

Downregulation of NUF2 Inhibits Tumor Growth and Induces Apoptosis by Regulating Lncrna AF339813.

The combination of NDUFS1 with CD4+ T cell infiltration predicts favorable prognosis in kidney renal clear cell carcinoma

The Role of Nephroblastoma Overexpressed Gene on Renal Cell Carcinoma

Targeting Of Ccn2 Suppresses Tumor Progression And Improves Chemo-Sensitivity In Urothelial Bladder Cancer